Incannex Healthcare Inc. (IXHL)
NASDAQ: IXHL · Real-Time Price · USD
3.590
-0.210 (-5.53%)
At close: Sep 17, 2026, 4:00 PM EDT
3.700
+0.110 (3.06%)
Pre-market: Sep 18, 2026, 5:29 AM EDT
Incannex Healthcare Employees
Incannex Healthcare had 12 employees as of June 30, 2025. The number of employees increased by 3 or 33.33% compared to the previous year.
Employees
12
Change (1Y)
3
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$4,034,500
Market Cap
42.95M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2025 | 12 | 3 | 33.33% |
| Jun 30, 2024 | 9 | 6 | 200.00% |
| Jun 30, 2021 | 3 | 1 | 50.00% |
| Jun 30, 2020 | 2 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| InterCure | 285 |
| Zhengye Biotechnology Holding | 269 |
| Universe Pharmaceuticals INC | 216 |
| China Pharma Holdings | 215 |
| Rockwell Medical | 157 |
| Aytu BioPharma | 83 |
| SCYNEXIS | 18 |
| Talphera | 12 |
IXHL News
- 8 days ago - Incannex doses first patient in DReAMzz study - TheFly
- 8 days ago - Incannex Healthcare Provides Corporate Update on Clinical Progress, Intellectual Property and Capital Position - GlobeNewsWire
- 23 days ago - Incannex doses first patient in DReAMzz study of IHL-42X - TheFly
- 23 days ago - Incannex Announces First Patient Dosed in DReAMzz Phase 2 Study of IHL-42X - GlobeNewsWire
- 5 weeks ago - Incannex receives additional A$5.1M R&D tax incentive refund - TheFly
- 1 month ago - Incannex commences screening in DReAMzz trial - TheFly
- 1 month ago - Incannex Commences Participant Screening in DReAMzz Phase 2 Study of IHL-42X for Obstructive Sleep Apnea - GlobeNewsWire
- 2 months ago - Incannex granted IHL-42X composition patent by USPTO - TheFly